Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 4
2009 1
2011 1
2012 1
2014 1
2015 2
2016 4
2017 5
2018 10
2019 7
2020 8
2021 13
2022 14
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche.
Winter S, Götze KS, Hecker JS, Metzeler KH, Guezguez B, Woods K, Medyouf H, Schäffer A, Schmitz M, Wehner R, Glauche I, Roeder I, Rauner M, Hofbauer LC, Platzbecker U. Winter S, et al. Among authors: gotze ks. Leukemia. 2024 May;38(5):936-946. doi: 10.1038/s41375-024-02226-6. Epub 2024 Mar 21. Leukemia. 2024. PMID: 38514772 Review.
Flipping the switch in the stem cell niche.
Götze KS. Götze KS. Blood. 2023 Aug 3;142(5):404-406. doi: 10.1182/blood.2023021286. Blood. 2023. PMID: 37535369 No abstract available.
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS.
Buck MC, Bast L, Hecker JS, Rivière J, Rothenberg-Thurley M, Vogel L, Wang D, Andrä I, Theis FJ, Bassermann F, Metzeler KH, Oostendorp RAJ, Marr C, Götze KS. Buck MC, et al. Among authors: gotze ks. iScience. 2023 Jul 10;26(8):107328. doi: 10.1016/j.isci.2023.107328. eCollection 2023 Aug 18. iScience. 2023. PMID: 37520699 Free PMC article.
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?
Baer C, Huber S, Hutter S, Meggendorfer M, Nadarajah N, Walter W, Platzbecker U, Götze KS, Kern W, Haferlach T, Hoermann G, Haferlach C. Baer C, et al. Among authors: gotze ks. Leukemia. 2023 Apr;37(4):938-941. doi: 10.1038/s41375-023-01831-1. Epub 2023 Feb 1. Leukemia. 2023. PMID: 36725896 Free PMC article. No abstract available.
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Rummelt C, Grishina O, Schmoor C, Crysandt M, Heuser M, Götze KS, Schlenk RF, Döhner K, Salih HR, Heil G, Müller-Tidow C, Brugger W, Kündgen A, De Wit M, Giagounidis A, Scholl S, Neubauer A, Krauter J, Bug G, Al-Ali HK, Wäsch R, Becker H, May AM, Duyster J, Hackanson B, Ganser A, Döhner H, Lübbert M. Rummelt C, et al. Among authors: gotze ks. Haematologica. 2023 Aug 1;108(8):2244-2248. doi: 10.3324/haematol.2022.282258. Haematologica. 2023. PMID: 36601981 Free PMC article. Clinical Trial. No abstract available.
78 results